Breaking News Bar

Business News and Information

AMAG Pharma licences oral mucositis treatment

Lexington-based Amag Pharmaceuticals Inc. (Nasdaq:AMAG) has paid $3.3 million to license MuGard, a prescription oral rinse for the treatment of oral mucositis, from Access Pharmaceuticals in the U...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear